Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Pharma Investments Reflect Key Industry Trends

August 2, 2014

Pharmaceutical Technology

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Analytical Labs Strive to Deliver More Information, Faster

August 1, 2014
Pharmaceutical Technology

Experts from contract testing laboratories and service organizations shared their perceptions of analytical testing advances, and challenges still ahead.

Weighing Clinical Trial Outsourcing Options

August 1, 2014

Pharmaceutical Technology

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.

Quality by Design in Contract Service Relationships

August 1, 2014
Pharmaceutical Technology

Contract service providers describe how quality by design has influenced a drug sponsor's expectations of suppliers.

Positive Outlook for Outsourcing

August 1, 2014

Pharmaceutical Technology

Contract services ride high as funding floods bio/pharma.

Europe's Need for Early Development Pharmaceutical Manufacturing Expertise

August 1, 2014

Pharmaceutical Technology

Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.

Outsourcing Grows in Europe

August 1, 2014

Pharmaceutical Technology Europe

Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.

Solid-Dosage Forms Demand Traditional and Emerging Technologies

August 1, 2014
Pharmaceutical Technology

Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.

CMOs Target Parenteral Drug Development Needs Both Large and Small

August 1, 2014
Pharmaceutical Technology

Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here